Background: Previous studies have reported a poor outcome for synovial sarcoma patients whose tumours relapse. Methods: This study analysed 44 relapsing cases in a series of 118 consecutive patients <21 yr of age with non-metastatic synovial sarcoma prospectively enrolled in Italian paediatric protocols between 1979 and 2006. In an effort to identify a possible risk-adapted stratification enabling a better planning of second-line treatment, the relapsing patients' outcome was analysed vis-a-vis their clinical picture at onset, first-line treatments, clinical findings at the time of first relapse and second-line treatment modalities. Results: The first event was a local recurrence in only 15 cases, and metastatic in 29 (associated with loc...
Introduction Synovial sarcoma accounts for 5% to 10% of malignant soft-tissue tumours. It occurs mor...
BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
Background: We aimed to evaluate prognostic factors and response rates to various treatment approach...
Background: Previous studies have reported a poor outcome for synovial sarcoma patients whose tumour...
International audienceTwenty-five to 32% of patients with synovial sarcoma (SS) relapse after approp...
Background: Malignant peripheral nerve sheath tumor (MPNST) is one of the most common nonrhabdomyosa...
BACKGROUND: Although > 90% of children with nonmetastatic rhabdomyosarcoma (RMS) achieve complete re...
Background: Childhood rhabdomyosarcoma (RMS), a soft tissue malignant tumor of skeletal muscle origi...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
Background: The benefit of adjuvant therapy in synovial sarcoma (SS) treatment is under debate. Long...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
Introduction Synovial sarcoma accounts for 5% to 10% of malignant soft-tissue tumours. It occurs mor...
BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
Background: We aimed to evaluate prognostic factors and response rates to various treatment approach...
Background: Previous studies have reported a poor outcome for synovial sarcoma patients whose tumour...
International audienceTwenty-five to 32% of patients with synovial sarcoma (SS) relapse after approp...
Background: Malignant peripheral nerve sheath tumor (MPNST) is one of the most common nonrhabdomyosa...
BACKGROUND: Although > 90% of children with nonmetastatic rhabdomyosarcoma (RMS) achieve complete re...
Background: Childhood rhabdomyosarcoma (RMS), a soft tissue malignant tumor of skeletal muscle origi...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
Background: The benefit of adjuvant therapy in synovial sarcoma (SS) treatment is under debate. Long...
BACKGROUND: To report the results of the first European prospective nonrandomized trial dedicated to...
PurposeSynovial sarcoma (SS) is the second most common malignant soft tissue tumor in children. ARST...
Introduction Synovial sarcoma accounts for 5% to 10% of malignant soft-tissue tumours. It occurs mor...
BACKGROUND: The outcome of patients with non-extremity synovial sarcoma (SS) is generally worse than...
Background: We aimed to evaluate prognostic factors and response rates to various treatment approach...